Person: Fasano, Alessio
Email Address
AA Acceptance Date
Birth Date
Research Projects
Organizational Units
Job Title
Last Name
First Name
Name
Search Results
Publication Indications and Use of the Gluten Contamination Elimination Diet for Patients with Non-Responsive Celiac Disease
(MDPI, 2017) Leonard, Maureen; Cureton, Pamela; Fasano, AlessioFor the majority of patients diagnosed with celiac disease, once a gluten-free diet is initiated, symptoms improve within weeks and may completely resolve in months. However, up to 30% of patients may show signs, symptoms or persistent small intestinal damage after one year on a gluten-free diet. These patients require evaluation for other common GI etiologies and assessment of their celiac disease status in order to make a diagnosis and suggest treatment. Here, we propose an approach to evaluating patients with celiac disease with persistent symptoms, persistently elevated serology, and or persistent villous atrophy despite a gluten-free diet. We detail how to diagnose and distinguish between non-responsive and refractory celiac disease. Finally, we introduce the indications for use of the gluten contamination elimination diet and provide information for practitioners to implement the diet when necessary in their practice.
Publication The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update
(MDPI, 2017) Catassi, Carlo; Alaedini, Armin; Bojarski, Christian; Bonaz, Bruno; Bouma, Gerd; Carroccio, Antonio; Castillejo, Gemma; De Magistris, Laura; Dieterich, Walburga; Di Liberto, Diana; Elli, Luca; Fasano, Alessio; Hadjivassiliou, Marios; Kurien, Matthew; Lionetti, Elena; Mulder, Chris J.; Rostami, Kamran; Sapone, Anna; Scherf, Katharina; Schuppan, Detlef; Trott, Nick; Volta, Umberto; Zevallos, Victor; Zopf, Yurdagül; Sanders, David S.Gluten-related disorders have recently been reclassified with an emerging scientific literature supporting the concept of non-celiac gluten sensitivity (NCGS). New research has specifically addressed prevalence, immune mechanisms, the recognition of non-immunoglobulin E (non-IgE) wheat allergy and overlap of NCGS with irritable bowel syndrome (IBS)-type symptoms. This review article will provide clinicians with an update that directly impacts on the management of a subgroup of their IBS patients whose symptoms are triggered by wheat ingestion.